Your case is filed under seal. Your employer is not notified.

Free reviewNo fee unless we recoverCases nationwide

The Whistleblower AdvocatesA practice of Kang Haggerty LLCConfidential line(833) 310-3147

Whistleblower Case Results

In short

Our attorneys have obtained a 9 million dollar settlement in a non-intervened fentanyl qui tam case, a 2 million dollar addiction treatment settlement in the Eastern District of Pennsylvania, and currently represent the relator in a False Claims Act case involving 275 million dollars in NIH grants at Harvard University.

$2,000,000
Addiction treatment / controlled substances · 2025 · U.S. Attorney's Office, Eastern District of Pennsylvania

$2 million False Claims Act settlement with Recovery Centers of America

Resolved allegations that RCA mishandled controlled substances in violation of the Controlled Substances Act and billed the government for inadequate treatment services in violation of the False Claims Act. The whistleblower, a former Outcomes Supervisor at RCA's King of Prussia headquarters, also settled an FCA anti-retaliation claim under 31 U.S.C. 3730(h).

The relator received $230,000 as her share of the recovery and separately settled a False Claims Act anti-retaliation claim for $450,000 plus costs and fees.

Attorneys: Edward T. Kang, Kandis L. Kovalsky, Ross M. Wolfe. Announcement

Government declined to intervene
$9,000,000
Pharmacy / opioid / private equity · 2023 · Federal

$9 million settlement in a non-intervened fentanyl qui tam case

Obtained a $9 million settlement in a NON-INTERVENED False Claims Act qui tam case against private equity firm Belhealth Investment Partners, its principals, and its pharmacy portfolio companies Linden Care and Quick Care, over prescriptions of Subsys, a rapid-onset fentanyl spray, dispensed for off-label and non-medically necessary uses billed to Medicare, Medicaid and TRICARE.

How we litigate cases the government declines

Attorneys: Edward T. Kang, Kandis L. Kovalsky, Ross M. Wolfe. Announcement

Pending
$275,000,000 in grants at issue
Research / NIH grant fraud · 2025 · U.S. District Court for the District of Massachusetts

Whistleblower suit against Harvard University over NIH grant administration

Represents Dr. David Searles Zielinski, former executive director of Harvard Catalyst, in a False Claims Act suit alleging Harvard University and Dr. Lee Nadler submitted fraudulent grant applications and failed to comply with federal grant regulations in administering NIH-funded research.

Attorneys: Kandis L. Kovalsky, Edward T. Kang, Ross M. Wolfe. Co-counsel: Whistleblower Law Collaborative, Boston, MA. Announcement

What these results do and do not mean

Prior results do not guarantee a similar outcome. Every case turns on its own facts, the strength of the evidence, and whether the government elects to intervene. Matters listed as pending are allegations that have not been resolved by any court.

These are matters handled by attorneys of Kang Haggerty LLC. For the full firm record, see Kang Haggerty LLC.

Talk to a whistleblower attorney before you report

A conversation costs nothing and is confidential. We will tell you honestly whether what you have describes a case, and what the first-to-file rule means for your timing.

Call (833) 310-3147 for a free confidential review